Health Canada

83 datasets found
  • Open Information

    COVID-19 guidance for reporting medical device shortages: Background

    Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The devices to which the shortages apply are on the List of Medical Devices — Notification of Shortages (specified medical devices).
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Regulatory considerations for importing or selling face shields: Notice to industry

    Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for reducing the risk of or preventing the user from infection. This includes COVID-19. Face shields may be authorized for sale or import into Canada through the following 3...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Health product advertising incidents related to COVID-19

    COVID-19 is a new disease not previously identified in humans. Health Canada is closely tracking all potential drugs and vaccines in development in Canada and abroad. We are working with companies, academic research centres and investigators to help expedite the development and availability of...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Helping people who use substances during the COVID-19 pandemic

    The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, as well as acute substance use harms. These crises are made worse in communities where there is chronic overcrowding, including a shortage of housing or other shelters.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Joint Statement on Clinical Trial Oversight in Canada

    Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Drug and vaccine authorizations for COVID-19: Overview

    Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    COVID-19 guidance for reporting medical device shortages: Background

    Under the Interim Order, manufacturers and importers must report medical device shortages related to COVID-19 to Health Canada. The devices to which the shortages apply are on the List of Medical Devices — Notification of Shortages (specified medical devices).
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Health product advertising incidents related to COVID-19

    COVID-19 is a new disease not previously identified in humans. Health Canada is closely tracking all potential drugs and vaccines in development in Canada and abroad. We are working with companies, academic research centres and investigators to help expedite the development and availability of...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Helping people who use substances during the COVID-19 pandemic

    The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, as well as acute substance use harms. These crises are made worse in communities where there is chronic overcrowding, including a shortage of housing or other shelters.
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Joint Statement on Clinical Trial Oversight in Canada

    Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB), recognize the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Open Information

    Regulatory considerations for importing or selling face shields: Notice to industry

    Most PPE, including face shields, are Class I medical devices if they are manufactured, sold or represented for use for reducing the risk of or preventing the user from infection. This includes COVID-19. Face shields may be authorized for sale or import into Canada through the following 3...
    Organization:
    Health Canada
    Resource Formats:
    • HTML
  • Proactive Publication

    APPEARANCE OF THE MINISTER OF HEALTH

    Briefing binder for the Minister of Health’s appearance at Committee of the Whole on April 20, 2020
    Organization:
    Health Canada
    Resource Formats:
    • PDF
  • Open Information

    Resources for Canadians living with pain during COVID-19: Resources

    The Government of Canada and the Canadian Pain Task Force (CPTF) recognize Canadians living with chronic pain need additional supports during COVID-19. The following list of supportive resources was assembled in collaboration with stakeholders and may be used by you and your partners in care to...
    Organization:
    Health Canada
    Resource Formats:
    • HTML